ROBO1 and hepatocellular carcinoma: However, it was revealed that ROBO1 is frequently expressed on the cell membrane in hepatocellular carcinoma, pediatric cancer, lung squamous cell carcinoma, pharyngeal cancer, and esophageal cancer, suggesting that CAR-T cell therapy targeting ROBO1 may be effective against these cancer types.